Results 121 to 130 of about 696 (142)

Food oral immunotherapy. [PDF]

Allergy Asthma Clin Immunol
McHenry M, Bégin P, Chan ES, Latrous M, Kim H.   +4 more
europepmc   +1 more source

Trends in food allergen immunotherapy in Korea after changed national regulations. [PDF]

Clin Exp Pediatr
Song TW.
europepmc   +1 more source

Peanut Allergy in Children-Is Prevention Better than Cure? [PDF]

Nutrients
Krejner-Bienias A, Łyżwa K, Krupa-Łaska A, Zielińska J, Kulus M, Grzela K.   +5 more
europepmc   +1 more source

Unravelling allergic rhinitis: exploring pathophysiology, advances in treatment, and future directions. [PDF]

Front Allergy
Singh AK, Shaili S, Siddiqui A, Ali A, Choubey A, Jain P, Mirza MA, Iqbal Z.   +7 more
europepmc   +1 more source

Allergen Immunotherapy: Pitfalls, Perks and Unexpected Allies. [PDF]

Int J Mol Sci
Tamaș TP, Ciurariu E.
europepmc   +1 more source

Allergic-Specific Immunotherapy Using Injectable <i>In Situ</i> Crosslinked Hyaluronic Acid Hydrogels Ameliorates Allergic Response in Murine Allergic Rhinitis Model. [PDF]

Allergy Asthma Immunol Res
Lee HJ, Kim JA, Lee Y, Lim S, Chun YH.
europepmc   +1 more source

Advances in Shellfish Allergy Therapy: From Current Approaches to Future Strategies. [PDF]

Clin Rev Allergy Immunol
Heidari S, Ruethers T, Karnaneedi S, Yin LWS, Lopata AL.   +4 more
europepmc   +1 more source

Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.

JAMA Pediatr
Petroni D, Bégin P, Bird JA, Brown-Whitehorn T, Chong HJ, Fleischer DM, Gagnon R, Jones SM, Leonard S, Makhija MM, Oriel RC, Shreffler WG, Sindher SB, Sussman GL, Yang WH, Bee KJ, Bois T, Campbell DE, Green TD, Rutault K, Sampson HA, Wood RA.   +21 more
europepmc   +1 more source

QUANTITATIVE RISK REDUCTION THROUGH EPICUTANEOUS IMMUNOTHERAPY (EPIT): RESULTS FROM THE PEPITES PHASE III TRIAL

Annals of Allergy, Asthma & Immunology, 2018
Introduction In a Phase 3, randomized, double-blind, placebo-controlled trial in children 4-11 years, daily EPIT with 250µg peanut patch (VP-250) was superior to placebo (p = 0.00001) in proportion of responders (based on peanut double-blind, placebo-controlled food challenge threshold change) after application for 12 months.
Benjamin C. Remington, Tanja Krone, Stef J. Koppelman   +2 more
openalex   +2 more sources